Human Genome-Wide Reduced Double-gRNA Library
(Pooled Library #137999)
-
Purpose
This lentiviral CRISPR knockout library enables genome-wide screens in human cell lines at reduced scale. Through optimization of guide RNA designs and delivery of two gRNAs with each construct a five-fold reduction in size is achieved without impacting performance compared with a sgRNA library with five gRNAs per target.
-
Vector Backbone
pKLV2-U6gRNA5(BbsI)-PGKpuro2ABFP-W (Plasmid #67974) - does not express Cas9
-
Depositing Labs
-
Publication
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | ||
---|---|---|---|---|---|---|
Pooled Library | 137999 | Human Genome-Wide Reduced Double-gRNA Library† | 1 | $540 | Add to Cart |
† A Cas9 plasmid is NOT included with this item and will have to be ordered separately. Can be used in conjunction with pKLV2-EF1a-Cas9Bsd-W (Addgene #68343) or other plasmids or cell lines expressing Cas9.
Library Details
-
SpeciesHuman
-
Genes targeted19,657
-
gRNAs59,576
-
Controls398 non-targeting controls
-
Lentiviral Generation3rd
Library Shipping
This library is delivered as suspended DNA in a microcentrifuge tube on blue ice. The tube's contents will not necessarily be frozen. For best results, minimize freeze/thaws.
-
Volume∼20 µL
-
Concentration50 ng/µL
Resource Information
-
Protocols
-
Depositor Data
-
Terms and Licenses
Academic/Nonprofit TermsIndustry Terms- Not Available to Industry
Trademarks- Zeocin® is an InvivoGen trademark.
Depositor Comments
Please visit https://www.biorxiv.org/content/10.1101/859652v1 (Link opens in a new window) for bioRxiv preprint.
These pooled libraries were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
Human Reduced Double-gRNA Library was a gift from Leopold Parts (Addgene #137999) -
For your References section:
Minimized double guide RNA libraries enable scale-limited CRISPR/Cas9 screens. Peets EM, Crepaldi L, Zhou Y, Allen F, Elmentaite R, Noell G, Turner G, Iyer V, Parts L. bioRxiv 859652. doi: 10.1101/859652. bioRxiv 859652